EMA Authorised: Intelence (Etravirine) — Janssen-Cilag International NV

View source ↗

Summary

The European Medicines Agency authorised Intelence (etravirine) for HIV infections, with Janssen-Cilag International NV as the marketing authorisation holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Intelence (Etravirine)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Janssen-Cilag International NV. Decision date: 08/08/2024